COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
In recognition of National Autism Awareness Month, Tricia Heitman of PCCA's clinical services team, discusses ways in which compounders help families and patients work to manage the obstacles autism presents.
FDA Updates with A.J. Day. An interview with the author of The Hormone Fix, Dr. Anna Cabeca, and a special interview with Cheri Kraemer, that and so much more from the Mortar & Pestle this month!
The experts in our Clinical Services and Formulation Development departments recommend Lipoderm as a first choice for customized transdermal medications. Here’s why.
Atopic dermatitis is the most common reason for dog and cat owners to visit their local veterinary clinic. It also affects other species, such as horses and ferrets. Deborah Clark of PCCA's Clinical Services team discusses how veterinary compounding can provide treatment options.
Rectal conditions can be difficult and painful to deal with, especially Crohn's disease, ulcerative proctitis and radiation proctitis. Nat Jones explains how compounding pharmacists have a unique knowledge to help those afflicted. He also provides specific formulation information geared toward providing relief.
Medicated lozenges are common in the pharmacy world. There's nothing common about NataTroche™ though, it's the first proprietary troche made with natural ingredients and free of polyethylene glycol or gelatin. Find out what makes NataTroche so special, and how it can help you and your patients.
Congratulations to Allan Baker, RPh, of Macdonalds Prescriptions in Vancouver, British Columbia, for being named our 2018 Canadian Compounding Pharmacist of the Year!
Jeff Gloyer is an engineer I with Eagle. He has experience working with multidisciplinary teams to implement the engineering design process. Here he discusses considerations that compounding pharmacies need to take in order to ensure they are USP <797> and <800> compliant.
Daniel Banov talks about water activity in various products and why they are becoming increasingly important in the pharmacy compounding world.
Tadalafil is now free of patents, and compounding pharmacies have some opportunities to use this drug in various customized medications. PCCA's Nat Jones drops in to tell us why that is such exciting news for compounding pharmacies and their patients.